Serum Concentration of Tranexamic Acid After Topical Administration in Massive Weight Loss Skin Reducing Surgery

PHASE2CompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

May 1, 2017

Primary Completion Date

February 28, 2018

Study Completion Date

February 28, 2018

Conditions
Surgical WoundBleeding
Interventions
DRUG

Tranexamic Acid 25 mg/ml for wound surface moistening

Wound surface moistened with 20 ml of tranexamic acid 25 mg/ml (total dose 500 mg) prior to wound closure

DRUG

Tranexamic Acid 5 mg/ml as bolus in wound cavity

200 ml of tranexamic acid 5 mg/ml (total dose 1 g) as a bolus instilled into the wound cavity after wound closure, which will remain in the cavity until the activation of drains one hour later

DRUG

Tranexamic Acid Injectable Solution

1 g of tranexamic acid administered intravenously in accordance with prevailing routines directly prior to planned surgical procedure.

Trial Locations (1)

Unknown

St Olavs Hospital, Trondheim

All Listed Sponsors
collaborator

Aleris Helse

OTHER

lead

St. Olavs Hospital

OTHER

NCT03101124 - Serum Concentration of Tranexamic Acid After Topical Administration in Massive Weight Loss Skin Reducing Surgery | Biotech Hunter | Biotech Hunter